Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -532 | -618 | 53 | 190 | 403 |
| Depreciation Amortization | 1,123 | 746 | 367 | 1,473 | 1,118 |
| Accounts receivable | 182 | -124 | -68 | -606 | -1,233 |
| Accounts payable and accrued liabilities | -14 | 138 | -75 | 245 | 435 |
| Other Working Capital | -80 | -102 | -76 | 304 | -967 |
| Other Operating Activity | -139 | -4 | 165 | 509 | 927 |
| Operating Cash Flow | $540 | $36 | $366 | $2,115 | $684 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -94 | -68 | -482 | -155 |
| Net Acquisitions | -450 | -300 | -300 | -300 | -300 |
| Sale Of Investment | 93 | 93 | 20 | 161 | 161 |
| Other Investing Activity | -648 | -379 | -179 | -1,136 | -839 |
| Investing Cash Flow | $-1,126 | $-680 | $-528 | $-1,758 | $-1,134 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -180 | -180 | -180 | 180 | 300 |
| Common Stock Issued | 174 | 87 | 1 | 22 | 13 |
| Other Financing Activity | -50 | -33 | -17 | 189 | 0 |
| Financing Cash Flow | $-56 | $-126 | $-196 | $391 | $313 |
| Beginning Cash Position | 1,236 | 1,236 | 1,236 | 488 | 488 |
| End Cash Position | 594 | 466 | 879 | 1,236 | 352 |
| Net Cash Flow | $-642 | $-770 | $-358 | $748 | $-136 |
| Free Cash Flow | |||||
| Operating Cash Flow | 540 | 36 | 366 | 2,115 | 684 |
| Capital Expenditure | -120 | -94 | -68 | -482 | -155 |
| Free Cash Flow | 420 | -58 | 298 | 1,632 | 529 |